Invalid controls undermine conclusions of FDA studies
Toxicological Sciences : an Official Journal of the Society of Toxicology
|September 19, 2014
Summary
This issue highlights diverse toxicology research, including green chemistry, mixture regulations, and carbon nanotube risk assessment. Discover cutting-edge studies spanning solvents, pesticides, nanoparticles, and the microbiome.
Area of Science:
- Toxicology
- Green Chemistry
- Risk Assessment
Background:
- This issue introduces "Look Inside ToxSci," featuring multiple high-quality research articles.
- An editorial explores the intersection of green chemistry and toxicology, identifying new opportunities.
- Articles address regulatory challenges of chemical mixtures and risk assessment for nanomaterials.
Discussion:
- The European Union's approach to regulating chemical mixtures is examined.
- Risk assessment strategies for carbon nanotubes are discussed.
- The integration of green chemistry principles into toxicological studies is emphasized.
Key Insights:
- Research spans diverse areas including solvents, pesticides, nanoparticles, and the microbiome.
- The importance of addressing complex regulatory landscapes for chemical mixtures is highlighted.
- Novel approaches to nanomaterial risk assessment are presented.
Outlook:
- Future toxicological research will benefit from green chemistry innovations.
- Continued focus on regulatory science for chemical mixtures and novel materials is expected.
- The breadth of topics covered indicates a dynamic and evolving field of toxicology.
Related Concept Videos
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
625
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
625
01:25Drug Regulation
2.9K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
2.9K
01:13Controls in Experiments
13.1K
When conducting an experiment, it is crucial to have control to reduce bias and accurately measure the dependent variables. It also marks the results more reliable. Controls are elements in an experiment that have the same characteristics as the treatment groups but are not affected by the independent variable. By sorting these data into control and experimental conditions, the relationship between the dependent and independent variables can be drawn. A randomized experiment always includes a...
13.1K
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
96
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure...
96
01:27Confounding in Epidemiological Studies
1.1K
Confounding in statistical epidemiology represents a pivotal challenge, referring to the distortion in the perceived relationship between an exposure and an outcome due to the presence of a third variable, known as a confounder. This variable is associated with both the exposure and the outcome but is not a direct link in their causal chain. Its presence can lead to erroneous interpretations of the exposure's effect, either exaggerating or underestimating the true association. This...
1.1K
01:26FDA Approved Drugs: Changes to Approved Drugs
340
Post-approval, manufacturers may modify an approved new or generic drug product. Such modifications can encompass alterations in the Active Pharmaceutical Ingredient (API), manufacturing process, formulation, batch size, manufacturing site, and container closure system (FDA Guidance for Industry, April 2004). Often, a drug product may undergo multiple changes.These modifications require careful evaluation to determine their potential impact on the drug product's identity, strength, quality,...
340